The FY2025 (Dec) proxy of Olema Pharmaceuticals names 28 peer companies for pay. Among Olema Pharmaceuticals and these peers, CEO pay was 13th highest of 15 and total shareholder return was the highest of 15.
13th highest of 15in Olema Pharmaceuticals and its pay peers, FY2025 (Dec) by CEO pay:
$2.3M$27.8M
1st highest of 15in Olema Pharmaceuticals and its pay peers, FY2025 (Dec) by total shareholder return:
$14$1,020
Pay peer group, FY2025 (Dec) proxy
| Cogent Biosciences | ||
| Arcus Biosciences | ||
| Praxis Precision Medicines | ||
| MeiraGTx Holdings | ||
| Vir Biotechnology | ||
| Arvinas | ||
| Anaptysbio | ||
| Oric Pharmaceuticals | ||
| Cullinan Therapeutics | ||
| Kura Oncology | ||
| Relay Therapeutics | ||
| Annexon | ||
| Keros Therapeutics | ||
| Verastem | ||
| Alector | Not disclosed | Not disclosed |
| Alumis | Not disclosed | Not disclosed |
| Amylyx Pharmaceuticals (amlx) | Not disclosed | Not disclosed |
| Arcturus Therapeutics Holdings | Not disclosed | Not disclosed |
| Aura Biosciences | Not disclosed | Not disclosed |
| Erasca | Not disclosed | Not disclosed |
| Inhibrx Biosciences | Not disclosed | Not disclosed |
| KalVista Pharmaceuticals | Not disclosed | Not disclosed |
| Kodiak Sciences | Not disclosed | Not disclosed |
| Nuvation Bio | Not disclosed | Not disclosed |
| Syndax Pharmaceuticals | Not disclosed | Not disclosed |
| Terns Pharmaceuticals | Not disclosed | Not disclosed |
| Xencor | Not disclosed | Not disclosed |
| Zenas BioPharma | Not disclosed | Not disclosed |
28 companies
Changes by year
No proxy on file names a change to the peer group.
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.